Progress in pathological diagnosis and clinical significance of diffuse pleural mesothelioma
10.3760/cma.j.cn112434-20220215-00046
- VernacularTitle:弥漫性胸膜间皮瘤多学科联合诊断进展及临床意义
- Author:
Keke YU
1
;
Jie ZHANG
;
Heng ZHAO
Author Information
1. 上海交通大学医学院附属胸科医院 上海市胸科医院病理科，上海 200030
- From:
Chinese Journal of Thoracic and Cardiovascular Surgery
2023;39(2):124-128
- CountryChina
- Language:Chinese
-
Abstract:
Diffuse pleural mesothelioma is a malignant mesothelioma, which is characterized by diffuse involvement of pleura or pericardium, strong invasion, high malignancy and poor prognosis. The onset of diffuse pleural mesothelioma is concealed. Most of them are in the late stage at the initial diagnosis. The treatment is difficult and the curative effect is poor. The 5-year survival rate is about 10%, and the median survival time is 7 to 9 months 1. Accurate pathological diagnosis and prognosis analysis are very important for patients to choose the most appropriate treatment. Therefore, it is urgent to make a fuller understanding of diffuse pleural mesothelioma on the basis of existing pathological research and clinical research evidence, so as to improve the level of standardized clinical diagnosis and treatment.
